$Lineage Cell Therapeutics (LCTX.US)$ Joseph Edelman just purchased 7 million shares. ARVO is May 4-8 FYI
The 41% ManEdelman
The 41% ManEdelman
$Veru Inc (VERU.US)$ The possibly for a buyout by NVO is plausible and a long play. VERU drug would help with the muscle loss from Ozempic and Wegovy that NVO manufacturers.
$Lineage Cell Therapeutics (LCTX.US)$CNN Report CEO discussed how stem cells are being used for paralized patients.
$Lineage Cell Therapeutics (LCTX.US)$ a reason why Roche is slow walking to trial in my opinion is that they can buy the company on the cheap instead of giving them 18% of the revenue they deserve…With all the outstanding shares, at a four dollar price tag it would give them a market cap of $1 billion… what would you do if you were Roche?
$Marker Therapeutics (MRKR.US)$ its been long enough for company to gather data and present. what do you say?
1
![Why would the Big Boys Invest in a $1 biotech?](https://ussnsimg.moomoo.com/sns_client_feed/74055349/20241112/e9343a0adeb7f60f5ccb287106566c5f.jpg/thumb?area=999&is_public=true)
2
$Lineage Cell Therapeutics (LCTX.US)$ forr those interested in what LCTX is doing
Stem cell research
Stem cell research
$Lineage Cell Therapeutics (LCTX.US)$ imho this is huge news… plus, milestone payment possible announcement… 11/14 er
![Blackrock purchased nearly 10 million shares…](https://ussnsimg.moomoo.com/sns_client_feed/74055349/20241109/48a86d29b39d09c39a7d36e37058f3cb.jpg/thumb?area=999&is_public=true)
![Blackrock purchased nearly 10 million shares…](https://ussnsimg.moomoo.com/sns_client_feed/74055349/20241109/62160e566cd41121bf744fe2175e1300.jpg/thumb?area=999&is_public=true)